3E Bioventures Capital is a healthcare focused venture investment fund. The core 3E investment team members are all trained in biomedical fields, with healthcare industry experience and years of successful investment or entrepreneurship experience in China. The 3E team combines good global industry perspectives with practical on the ground China experiences. The team’s past investment portfolio companies cover areas such as drug, device, diagnostics, healthcare IT and medical services. 3E Bioventures Capital currently manages both RMB and US Dollar funds, investing in early and growing stage companies in China and the United States. We believe in the huge industry growth and significant investment opportunities in China healthcare space for the next 10 to 20 years. We aim to leverage our healthcare expertise and experience to ride this historic opportunity, to help build successful healthcare ventures and technologies, to generate good return for our investors, and at the same time, to build 3E Bioventures into a significant international healthcare investment brand.
32
Total Investments
26
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Financial Services, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About 3E Bioventures Capital
Recent Investments (32)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jan 2024 | |
| Seed Round | •••••• | Nov 2023 | |
| Series A | •••••• | Jul 2023 | |
| Series B | •••••• | Jun 2023 | |
| Series A | •••••• | May 2023 | |
|
|
Series A | •••••• | May 2023 |
|
|
Series B | •••••• | Feb 2023 |
|
|
Angel Round | •••••• | Jan 2023 |
|
|
Series B | •••••• | Aug 2022 |
|
|
Series B | •••••• | Mar 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.